These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8846226)

  • 1. A paradigm for drug discovery using a conformation from the crystal structure of a presentation scaffold.
    Zhao B; Helms LR; DesJarlais RL; Abdel-Meguid SS; Wetzel R
    Nat Struct Biol; 1995 Dec; 2(12):1131-7. PubMed ID: 8846226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong inhibition of fibrinogen binding to platelet receptor alpha IIb beta 3 by RGD sequences installed into a presentation scaffold.
    Lee G; Chan W; Hurle MR; DesJarlais RL; Watson F; Sathe GM; Wetzel R
    Protein Eng; 1993 Sep; 6(7):745-54. PubMed ID: 8248098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics simulations of certain RGD-based peptides from Kistrin provide insight into the higher activity of REI-RGD34 protein at higher temperature.
    Upadhyay SK
    Chem Biol Drug Des; 2014 May; 83(5):600-9. PubMed ID: 24877256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic excision and in situ cyclization of a bioactive loop from an REI-VL presentation scaffold.
    Helms LR; Wetzel R
    Protein Sci; 1994 Jul; 3(7):1108-13. PubMed ID: 7920257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
    Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
    Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the principal binding site for RGD-containing ligands in the alpha(V)beta(3) integrin: a photoaffinity cross-linking study.
    Yahalom D; Wittelsberger A; Mierke DF; Rosenblatt M; Alexander JM; Chorev M
    Biochemistry; 2002 Jul; 41(26):8321-31. PubMed ID: 12081480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD.
    Fujii Y; Okuda D; Fujimoto Z; Horii K; Morita T; Mizuno H
    J Mol Biol; 2003 Oct; 332(5):1115-22. PubMed ID: 14499613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of conformational specificity at GPIIb/IIIa: evaluation of conformationally constrained RGD peptides.
    Peishoff CE; Ali FE; Bean JW; Calvo R; D'Ambrosio CA; Eggleston DS; Hwang SM; Kline TP; Koster PF; Nichols A
    J Med Chem; 1992 Oct; 35(21):3962-9. PubMed ID: 1433203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists.
    Cheng S; Craig WS; Mullen D; Tschopp JF; Dixon D; Pierschbacher MD
    J Med Chem; 1994 Jan; 37(1):1-8. PubMed ID: 7507165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S; Lu X; Kakkar VV; Authi KS
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidomimetics - antagonists of the fibrinogen receptors: molecular design, structures, properties and therapeutic applications.
    Andronati SA; Karaseva TL; Krysko AA
    Curr Med Chem; 2004 May; 11(9):1183-211. PubMed ID: 15134514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis and modeling of a conformationally constrained Arg-Gly-Asp sequence inserted into human lysozyme.
    Yamada T; Uyeda A; Kidera A; Kikuchi M
    Biochemistry; 1994 Oct; 33(39):11678-83. PubMed ID: 7522552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa).
    Du XP; Plow EF; Frelinger AL; O'Toole TE; Loftus JC; Ginsberg MH
    Cell; 1991 May; 65(3):409-16. PubMed ID: 2018974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of gamma-bungarotoxin: the functional significance of amino acid residues flanking the RGD motif in integrin binding.
    Shiu JH; Chen CY; Chang LS; Chen YC; Chen YC; Lo YH; Liu YC; Chuang WJ
    Proteins; 2004 Dec; 57(4):839-49. PubMed ID: 15390258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RGD-mutants of B-lymphotropic polyomavirus capsids specifically bind to alpha(v)beta3 integrin.
    Langner J; Neumann B; Goodman SL; Pawlita M
    Arch Virol; 2004 Oct; 149(10):1877-96. PubMed ID: 15290355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region.
    Leahy DJ; Aukhil I; Erickson HP
    Cell; 1996 Jan; 84(1):155-64. PubMed ID: 8548820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common molecular scaffold for two unrelated RGD molecules.
    Ely KR; Kunicki TJ; Kodandapani R
    Protein Eng; 1995 Aug; 8(8):823-7. PubMed ID: 8637852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT; Serrano L; Wilmanns M
    J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR solution structure of alpha-conotoxin ImI and comparison to other conotoxins specific for neuronal nicotinic acetylcholine receptors.
    Rogers JP; Luginbühl P; Shen GS; McCabe RT; Stevens RC; Wemmer DE
    Biochemistry; 1999 Mar; 38(13):3874-82. PubMed ID: 10194298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.